MLCK inhibitor peptide 18
Biological ActivitySelective competitive inhibitor of myosin light chain kinase (IC50 = 50 nM). Displays 4000-fold selectivity over CaM kinase II and does not inhibit PKA. Cell permeable.
(Modifications: Lys-9 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis. All Tocris products are intended for laboratory research use only.
A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease.
Zolotarevsky et al.
Identification of novel classes of protein kinase inhibitors using combinatorial peptide chemistry based on functional genomics knowledge.
Lukas et al.
Citation for MLCK inhibitor peptide 18
The citations listed below are publications that use Tocris products. Selected citations for MLCK inhibitor peptide 18 include:
1 Citation: Showing 1 - 1
Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes.
Authors: Wang Et al.
Proc Natl Acad Sci U S A 2012;61:2134
No product specific FAQs exist for this product, however you mayView all Peptide FAQs
Reviews for MLCK inhibitor peptide 18
There are currently no reviews for this product. Be the first to review MLCK inhibitor peptide 18 and earn rewards!
Have you used MLCK inhibitor peptide 18?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image